Structure |
Chemical Name |
CAS |
MF |
|
3-[2-(3,4-Dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-on |
15462-91-6 |
C22H26O6 |
|
α-[4-[2-(Diethylamino)ethoxy]phenyl]-α-phenylphenethylalkohol |
73404-00-9 |
C26H31NO2 |
|
2-(Aminoacetylamino)-3-(o-chlorobenzoyl)-5-ethylthiophene |
50509-09-6 |
C15H15ClN2O2S |
|
JLEQLXGZAIAEFX-VRQJEYPFSA-N |
1795790-92-9 |
C22H19N3O5 |
|
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochlorid |
1422956-25-9 |
C28H31ClN4O3 |
|
Intermediate 1 |
2203433-07-0 |
C17H16N2O5 |
|
(R)-1-acetyl-5-[2-(phenylsulfonyl)ethyenyl]-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole |
180637-88-1 |
C24H26N2O3S |
|
Velpatasvir intermediate |
1378391-43-5 |
C44H55N3O13 |
|
4-amino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid |
130525-62-1 |
C11H18N2O7 |
|
(1S,3R,4S)-Ethyl 4-AMino-3-((tert-butoxycarbonyl)aMino)cyclohexanecarboxylate Oxalate |
1093351-24-6 |
C16H28N2O8 |
|
Vorapaxar |
900161-12-8 |
C29H34N2O5 |
|
1-Pyrrolidinepropanol, β-amino-α-(2,3-dihydro-1,4-benzodioxin-6-yl)-, (αR,βR)- |
491833-28-4 |
C15H22N2O3 |
|
TF-BF |
209861-00-7 |
C24H22F2O5 |
|
Indacaterol interMediate |
435273-75-9 |
C31H34N2O3 |
|
N,N-Diphenyl-1H-imidazole-1-carboxamide |
2875-79-8 |
C16H13N3O |
|
Otilonium Bromide intermediates |
51444-79-2 |
C22H27NO4 |
|
(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone |
1027552-46-0 |
C21H22FNO3 |
|
tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate |
177423-00-6 |
C19H38N2O4 |
|
Levofloxacin R-Isomer HCl |
|
|
|
Tadanafil intermediate (chloroacetyl porphyrin) |
171596-59-1 |
C31H57BN4O6Si |
|
2,5-Dihydro-5-thioxo-1H-tetrazol-1-methansulfonsure |
67146-22-9 |
C2H4N4O3S2 |
|
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
|
4-MAR |
|
|
|
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
|
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
|
Lysergamide, 1-acetyl-N,N-diethyl- (6CI,7CI) |
3270-02-8 |
C22H27N3O2 |
|
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
|
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
|
Sugammadex sodium hexabromide intermediate |
|
|
|
Acetoxy Ceftazidime Intermediate |
|
|
|
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
|
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- |
852148-49-3 |
C21H22FNO4 |
|
6-(Phthalimidomethyl)morphanthridine |
74860-00-7 |
C23H16N2O2 |
|
RTI 4229-111 |
150653-91-1 |
C16H20Cl3NO2 |
|
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate |
900186-73-4 |
C26H26N2O5 |
|
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
|
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
|
1,1-Dimethylethyl 10,10-dimethyl-8-oxo-3,9-dioxa-2,7-diazaundecanoate |
1243021-74-0 |
C13H26N2O5 |
|
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
|
[402960-19-4],C9H18N2O2, 186.40 |
850252-34-5 |
C9H19ClN2O2 |
|
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone |
530084-79-8 |
C18H16BrNO3 |
|
EthanediaMide iMpurity F hcl |
482375-18-8 |
C2H4N2O2 |
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1702274-61-0 |
C20H25N5 |
|
Sugammadex sodium Heptabromide intermediate |
|
|
|
6-Methyleneandrost-4-ene-3,17-dione |
19457-55-7 |
C20H26O2 |
|
455284-06-7 |
455284-06-7 |
|
|
1-Acetyl-4-(4-hydroxyphenyl)piperazine side chain of Ketoconazole |
67914-99-2 |
C13H18N2O3 |
|
(R)-Levofloxacin |
|
C18H20FN3O4 |
|
Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)- (acetate) |
906093-30-9 |
C16H22N4O2 |
|
Ofloxacin EP Impurity C |
95848-94-5 |
C18H21N3O4 |
|
3,3-Ethylenedioxy-17β-cyano-17α-trimethylsilyloxyestra-5(10)9(11)-diene |
54690-63-0 |
C24H35NO3Si |
|
(4-bromo-2-fluorophenyl)-(3,4,5-trimethoxyphenyl)methanone |
1016544-26-5 |
C16H14BrFO4 |
|
Sugammadex sodium Pentabromide intermediate |
|
|
|
Itraconzole intermediate |
|
|
|
Prostaglandin E2-biotin |
|
C35H58N4O6S |
|
(3R,5S,2R,3S)-posaconazole |
|
|
|
DELTA12-PROSTAGLANDIN J2 |
87893-54-7 |
C20H30O4 |
|
Oseltamivir Fructose Adduct 5 |
|
|
|
Oseltamivir Glucose Adduct 3 |
|
|
|
11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2 |
109826-53-1 |
C20H30O4 |
|
9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID |
802-31-3 |
C20H30O5 |
|
PROSTAGLANDIN F1ALPHA |
745-62-0 |
C20H36O5 |
|
1-[(2S)-2-(benzyloxy)propanoyl]pyrrolidine |
122151-32-0 |
C14H19NO2 |
|
Oseltamivir Fructose Adduct 1 |
|
|
|
(3R,4S,5S)-Oseltamivir |
|
|
|
INDEX NAME NOT YET ASSIGNED |
2070009-39-9 |
C35H39N5O10 |
|
(9H-fluoren-9-yl)methyl ((2S,3R)-3-hydroxy-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
Posaconazole EnantioMer |
|
|
|
Posaconazole Diastereoisomer 12 |
213381-04-5 |
C37H42F2N8O4 |
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-98-8 |
C37H42F2N8O4 |
|
17-PHENYL TRINOR PROSTAGLANDIN E2 |
38315-43-4 |
C23H30O5 |
|
PROSTAGLANDIN D2 |
41598-07-6 |
C20H32O5 |
|
Oseltamivir Glucose Adduct 1 |
|
|
|
(3R,5R,2R,3S)-posaconazole |
|
|
|
(9H-fluoren-9-yl)methyl (R)-(1-(methylamino)-1-oxo-3-(pyridin-4-yl)propan-2-yl)carbamate |
|
|
|
(9H-fluoren-9-yl)methyl (S)-(1-cyclohexyl-2-(methylamino)-2-oxoethyl)carbamate |
|
|
|
9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
211105-29-2 |
C20H28D4O5 |
|
(3R,5S,2S,3S)-posaconazole |
|
|
|
(3R,4S,5R)-Oseltamivir |
|
|
|
(9H-fluoren-9-yl)methyl (R)-(3-(4-chlorophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
|
Oseltamivir-13CD3 |
1093851-61-6 |
C16H28N2O4 |
|
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
|
(3S,4S,5S)-Oseltamivir |
|
|
|
(9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
1246391-73-0 |
C37H42F2N8O4 |
|
(9H-fluoren-9-yl)methyl (4-(dimethoxymethyl)phenyl)carbamate |
475160-88-4 |
C24H23NO4 |
|
Posaconazole Impurity 18 |
213381-06-7 |
C37H42F2N8O4 |
|
(9H-fluoren-9-yl)methyl (S)-(1-(methylamino)-1-oxo-5-ureidopentan-2-yl)carbamate |
|
|
|
(9H-fluoren-9-yl)methyl (S)-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate |
|
|
|
(Ac)Phe-Lys(Alloc)-PABC-PNP |
|
C??H??N?O?? |
|
4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
170985-61-2 |
C37H42F2N8O4 |
|
(3S,5R,2R,3S)-posaconazole |
|
|
|
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
|
(3R,4R,5R)-Oseltamivir |
|
|
|
(9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
|
Posaconazole Impurity 16 |
213381-02-3 |
C37H42F2N8O4 |
|
(3S,4R,5R)-Oseltamivir |
|
|
|
Posaconazole Diastereoisomer 11 |
171228-50-5 |
C37H42F2N8O4 |
|
Oseltamivir Fructose Adduct 2 |
|
|
|
(3S,5S,2S,3R)-posaconazole |
|
|